Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy

AIM: The objective of the study was to detect changes in quality of life (QoL) in metastatic breast cancer patients treated with metronomic chemotherapy with daily low doses of cyclophosphamide and celecoxib. MATERIAL & METHODS: Patients included in a Phase II trial, treated with metronomic cycl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Future Oncol
Autors principals: Perroud, Herman A, Alasino, Carlos M, Rico, Maria J, Queralt, Francisco, Pezzotto, Stella M, Rozados, Viviana R, Scharovsky, O Graciela
Format: Artigo
Idioma:Inglês
Publicat: Future Medicine Ltd 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4976839/
https://ncbi.nlm.nih.gov/pubmed/26948919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2016-0075
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars